SCHEMBL6958706

SCHEMBL6958706

CS(=O)(=O)O[C@H]1CCc2c(F)cc(F)cc2C1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
EPAS1 Q99814 2/20 0.32
HCRTR2 O43614 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6954469 1.00 EPAS1 (0.32) EPAS1HCRTR2
SCHEMBL4370917 1.00 EPAS1 (0.32) EPAS1HCRTR2
SCHEMBL6954328 0.89 HTR6 (0.32) HCRTR2
SCHEMBL6957962 0.89 HTR6 (0.32) HCRTR2
SCHEMBL6954336 0.89 HTR6 (0.32) HCRTR2
SCHEMBL8613236 0.87 PARP1 (0.30)
SCHEMBL6954327 0.80 DRD2 (0.51)
SCHEMBL6954331 0.80 DRD2 (0.51)
SCHEMBL6958607 0.80 DRD2 (0.51)
SCHEMBL6951218 0.79 HDAC8 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0757677-B1 BENZOCYCLOHEXYLIMIDAZOLETHIONE DERIVATIVES SYNTEX LLC (US) 2003-06-18 EP disclosed
US-5719280-A REACTING AMINE SUBSTITUTED BENZOCYCLOALKANE WITH DIALKYLOXYACETALDEHYDE IN PRESENCE OF REDUCING AGENT OR CATALYTIC HYDROGENATION, TREATING WITH THIOCYANIC ACID SYNTEX (U.S.A.) INC. (US) 1998-02-17 US disclosed
US-5538988-A CARDIOVASCULAR DISORDERS AND DOPAMINE HYDROLASE ENZYME INHIBITORS SYNTEX (U.S.A.) INC. 1996-07-23 US disclosed